Skip to main content
CNFN
OTC Trade & Services

CFN Enterprises Reports Dire 2025 Results, Going Concern Doubt, and CSO Termination Amidst Revenue Collapse

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
9
Price
$0.55
Mkt Cap
$4.72M
52W Low
$0.55
52W High
$10
52W Position info
0.0% above low
Off High info
95% below high
Rel. Volume info
4.0× avg
Market data snapshot near publication time

CNFN is trading near its 52-week low of $0.55 (0.0% above the low) on elevated volume (4.0× avg).

Summary

CFN Enterprises Inc. reported a substantial doubt about its ability to continue as a going concern, an 89% drop in continuing operations revenue, and a significant increase in net loss for fiscal year 2025, alongside the termination of its Chief Strategy Officer for cause.


Key Events · Earnings and Guidance · CNFN

  • Substantial Doubt About Going Concern

    Both management and the independent auditor expressed substantial doubt about the company's ability to continue as a going concern, citing recurring losses and dependence on external financing.

  • Catastrophic Revenue Decline

    Net revenues from continuing operations plummeted 89% to $36,297 in 2025 from $321,352 in 2024, primarily due to reduced sponsored content activity.

  • Increased Net Loss and Working Capital Deficit

    Total net loss increased to $6,815,238 in 2025 from $4,529,362 in 2024. The working capital deficit expanded to $23,975,387 as of December 31, 2025.

  • Discontinuation of Ranco Operations

    The Ranco LLC segment, a significant revenue contributor, was discontinued in Q4 2025 following a national ban on intoxicating hemp-derived consumable products (H.R. 5371), resulting in $1,998,538 in impairment charges and $13.3 million in current liabilities from discontinued operations.


Analysis · CNFN · Trade & Services

This annual report reveals a company in severe financial distress, with both management and auditors expressing substantial doubt about its ability to continue as a going concern. The drastic 89% decline in continuing operations revenue, coupled with a significant increase in net loss, highlights a critical deterioration in financial performance. The discontinuation of the Ranco LLC segment due to a regulatory ban on hemp products, which was a major revenue contributor, has left the company with substantial liabilities and a working capital deficit. Multiple debt defaults and ineffective internal controls further compound the risks, indicating significant operational and governance challenges. The recent termination of the Chief Strategy Officer for cause adds to the negative sentiment and raises questions about leadership stability during this critical period. Investors should be aware of the extreme financial fragility and high operational risk.

At the time of this filing, CNFN was trading at $0.55 on OTC in the Trade & Services sector, with a market capitalization of approximately $4.7M. The 52-week trading range was $0.55 to $10.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CNFN - Latest Insights

CNFN
May 20, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.899544
Real-time Price: $0.5801 info
Change: -$0.319444 (-36%) info
Market Cap: $5.19M info
CNFN
Apr 15, 2026, 4:15 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.550
Real-time Price: $0.5801 info
Change: +$0.0301 (+5%) info
Market Cap: $5.19M info